Overview
- Major League Baseball announced Friday that Kepler tested positive for epitrenbolone, a metabolite of the anabolic steroid trenbolone.
- Kepler accepted the discipline without filing a grievance, according to a person familiar with the process who spoke to the Associated Press.
- Under the league’s Joint Drug Agreement, the suspension covers regular-season and postseason games in which he would have been eligible to play.
- As a free agent, he can serve the 80-game ban while unsigned and would not be paid for any portion of the suspension served under contract.
- The 11-year veteran hit .216 with 18 home runs and 52 RBIs for the Phillies in 2025, and MLB says this is the first publicly announced epitrenbolone suspension since detailed disclosures began in 2005.